Paasa Logo
Renascience Inc. logo
4889JPXMarket closedOpens 9:00am JST

Renascience Inc.

¥1,218.00Last updated
+¥47.00 (4.01%)Past day
Timezone

Renascience Inc. (JPX: 4889) is trading at ¥1,218.00, about ₹742 at today's JPY/INR rate, as of 25 Sep 2026, 2:30 AM ET, up 4.01% today. Indian residents can buy Renascience from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:¥1,175.00
Previous close:¥1,171.00
Volume:482.80K

Today's low

¥1,165.00

Today's high

¥1,297.00

52 week low

¥1,101.00

52 week high

¥2,342.00

4889 opened at ¥1,175.00, closed previously at ¥1,171.00, and has traded between ¥1,101.00 and ¥2,342.00 over the past 52 weeks.

About

Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.

Country
JP
CEO
Toshio Miyata
Exchange listed on
JPX
Industry
Medical - Pharmaceuticals
Base currency
JPY
Full Time Employees
3
Sector
Healthcare
IPO date
24/09/2021

Key statistics

Avg. volume

467.10K

Market cap

¥16.78B

P/E Ratio

-50.58

Price-to-sales ratio

244.77

Enterprise value

¥13.58B

Free cash flow yield

0.00%

Debt-to-equity ratio

0.00

Return on equity

-12.00%

ROIC

-10.39%

Beta

1.68

Dividend yield

0.00%

Last dividend

¥0.00

Financial overview

Revenue

¥68.55M

Earnings per share

-¥23.39

Free cash flow

-¥291.31M

Net profit margin

-461.59%

Gross margin

93.66%

EBITDA

-¥356.88M

Revenue growth

-48.34%

Similar securities

This is not an investment recommendation

How to buy Renascience from India

Indian residents can buy Renascience shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.

  3. Search for Renascience and place an order

    Find Renascience by name or by its ticker, 4889, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Renascience trades 5:30 am – 12:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Renascience position in JPY and INR. Renascience pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Renascience from India

Trading and taxes when buying Renascience from India

Trading and limits

Trading hours
9:00 am – 3:30 pm JST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneRenascience does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Estate or inheritance tax
May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Renascience stock?

Yes. Renascience (4889) has been listed on the Tokyo Stock Exchange since 2021, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Renascience share cost in rupees?

One Renascience share is ¥1,218.00 — about ₹742 at a JPY/INR rate of 0.6089 on 25 Sep 2026. Both the Renascience price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Renascience from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Renascience?

The Tokyo Stock Exchange typically trades in units of 100 shares.

How are gains on Renascience shares taxed in India?

Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Renascience price. Paasa issues a capital-gains statement for your return.

Does Renascience pay a dividend?

No. Renascience does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Renascience from India?

The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.

Is there estate or inheritance tax on Renascience shares held from India?

Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.

Do I have to declare Renascience shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Renascience holding, its cost and its closing value.

How do I sell Renascience and bring the money back to India?

You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.